Gevarra, Jaycob B.

HRN: 23-72-50  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2023
CEFTRIAXONE 1G (VIAL)
09/22/2023
09/28/2023
IVTT
315mg
IVTT
PCAP-C
Checking Final Appropriateness 
09/23/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/23/2023
10/23/2023
IV
68mg
Q24H
PCAP C
Waiting Final Action 
06/07/2025
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
06/07/2025
06/11/2025
PO
1.5ml
OD
PCAP C
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: